Evidence map›Paper›PMID 22262481›Full record

ArticleAmerican journal of physiology. Renal physiology2012

Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes.

Yoshinori Taniguchi, Jeffrey W Pippin, Henning Hagmann, Ronald D Krofft, Alice M Chang, Jiong Zhang, Yoshio Terada, Paul Brinkkoetter, Stuart J Shankland

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Proline-dependent and basophilic kinases phosphorylate human TRPC6 at serine 14 to control channel activity through increased membrane expression.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Changes in glomerular parietal epithelial cells in mouse kidneys with advanced age.American journal of physiology. Renal physiology · 2015
    Article
  12. Article
  13. Cells of renin lineage take on a podocyte phenotype in aging nephropathy.American journal of physiology. Renal physiology · 2014
    Article
  14. Article
  15. Article
  16. Cdk5: An Emerging Kinase in Pain Signaling.Brain disorders & therapy · 2013
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Yoshinori TaniguchiDivision of Nephrology, Department of Medicine, University of Washington, Seattle, WA 98195-6521, USA.
Jeffrey W Pippin
Henning Hagmann
Ronald D Krofft
Alice M Chang
Jiong Zhang
Yoshio Terada
Paul Brinkkoetter
Stuart J Shankland
University of Washington · USCologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases · DEKochi Medical School Hospital · JPUniversity of Cologne · DE

Funding

CELL CYCLE PROTEINS AND GLOMERULAR APOPTOSISR01DK056799 · NIDDK · UNIVERSITY OF WASHINGTON · PI SHANKLAND, STUART JAMES · 2000 to 2014
$3.6M
CELL CYCLE CONTROL IN GLOMERULAR DISEASER01DK051096 · NIDDK · UNIVERSITY OF WASHINGTON · PI SHANKLAND, STUART JAMES · 1997 to 2007
$1.8M
MECHANISMS OF PODOCYTE INJURYR01DK060525 · NIDDK · UNIVERSITY OF WASHINGTON · PI SHANKLAND, STUART · 2002 to 2005
$1.1M
NIDDK NIH HHS DK51096NIDDK NIH HHS DK56799NIDDK NIH HHS DK60525
6 · The paper itself

Abstract

Cyclin-dependent kinase (Cdk)-5 is activated by both cyclin I and the noncyclin activator p35 in terminally differentiated cells such as kidney podocytes and neurons. Cyclin I and p35 are restricted to podocytes in the kidney, and each limit podocyte apoptosis by activating Cdk5. To determine whether both activators are necessary, or whether they serve backup roles, a double cyclin I-p35 null mouse was generated. Experimental glomerular disease characterized by podocyte apoptosis was then induced by administering an anti-podocyte antibody. The results showed that under nonstressed conditions double mutants had normal kidney structure and function and were indistinguishable from wild-type, cyclin I(-/-), or p35(-/-) mice. In contrast, when stressed with disease, podocyte apoptosis increased fourfold compared with diseased cyclin I(-/-) or p35(-/-) mice. This resulted in a more pronounced decrease in podocyte number, proteinuria, and glomerulosclerosis. Under normal states and nephritic states, levels for the prosurvival protein Bcl-2 were lower in double cyclin I(-/-) p35(-/-) mice than the other mice. Similarly, levels of Bcl-xL, another prosurvival member, were lower in normal and nephritic double cyclin I(-/-) p35(-/-) mice but similar to single-cyclin I(-/-) mice. Moreover, levels of ERK1/2 and MEK1/2 activation were lower in nephritic double cyclin I(-/-) p35(-/-) mice but similar to single-cyclin I(-/-) mice. The results demonstrate that the activators of Cdk5, p35, and cyclin I are not required for normal kidney function. However, they play pivotal coordinated roles in maintaining podocyte survival during stress states in disease.

Indexed as

AnimalsAntibodies, Anti-IdiotypicApoptosisbcl-X ProteinCell SurvivalCyclin-Dependent Kinase 5Cyclin IDisease Models, AnimalKidney DiseasesMAP Kinase Kinase 1MAP Kinase Kinase 2MiceMice, KnockoutMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PhosphotransferasesAntibodies, Anti-IdiotypicBcl2l1 protein, mousebcl-X ProteinCcni protein, mouseCdk5 protein, mouseCdk5r1 protein, mouseCyclin-Dependent Kinase 5Cyclin IMAP Kinase Kinase 1MAP Kinase Kinase 2Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PhosphotransferasesProto-Oncogene Proteins c-bcl-2

Identifiers

PMID22262481
PMCPMC3362174
OpenAlexW2003450755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.